Control Bionics (ASX: CBL) registers NeuroStrip with US FDA as commercial execution becomes the next test
Read More Pharma Industry News Aspirin no longer recommended for preventing heart attack or stroke in older adults A seven-year study has found that daily aspirin intake does not lower the risk of heart attack or… bypharmanewsdailySeptember 19, 2018
